US OptionsDetailed Quotes
HIMS241227P30500
- 4.04
- 0.000.00%
15min DelayClose Dec 27 16:00 ET
0.00High0.00Low
0.00Open4.04Pre Close0 Volume0 Open Interest30.50Strike Price0.00Turnover0.00%IV-9.43%PremiumDec 27, 2024Expiry Date6.32Intrinsic Value100Multiplier-3DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type--Delta--Gamma5.99Leverage Ratio--Theta--Rho--Eff Leverage--Vega
Hims & Hers Health Stock Discussion
Sign in to post a comment
$Hims & Hers Health (HIMS.US)$ looks like gonna downtrend more
1
$Hims & Hers Health (HIMS.US)$
Super bullish. Biggest reason to invest in this company in 2025.
Super bullish. Biggest reason to invest in this company in 2025.
2
1
$Hims & Hers Health (HIMS.US)$ those follow my post would hv sold at the top 30 from 25.5 before we drop to 26.56.
Moving to next week, will be tricky. Breaking 25.5 I am closing my position. Its about holding this support line.
Stil hoping to close 30 to hv a more bullish momentum for 2025. But dont hav high expectation on this guys.![]()
Moving to next week, will be tricky. Breaking 25.5 I am closing my position. Its about holding this support line.
Stil hoping to close 30 to hv a more bullish momentum for 2025. But dont hav high expectation on this guys.
5
6
$Hims & Hers Health (HIMS.US)$ Summary
Hims & Hers Health is revolutionizing telehealth with a vertically integrated model, offering personalized medications and achieving rapid subscription growth, driving long-term profitability and differentiation.
HIMS' financials are robust, with 40% annual subscription growth and a forecasted 60%+ revenue growth for 2024, indicating significant undervaluation despite a 200% YTD increase.
The company is expanding its product offerings and leveraging AI th...
Hims & Hers Health is revolutionizing telehealth with a vertically integrated model, offering personalized medications and achieving rapid subscription growth, driving long-term profitability and differentiation.
HIMS' financials are robust, with 40% annual subscription growth and a forecasted 60%+ revenue growth for 2024, indicating significant undervaluation despite a 200% YTD increase.
The company is expanding its product offerings and leveraging AI th...
4
$Hims & Hers Health (HIMS.US)$ while last week broader market was red, i hope thats the bottom. We shld see a bounce this shorter trading week.
Those enter to trade at 25.5 this week is the time to unload at 29/30. I expect some resistance and goin back down. Breaking 25.5 i see further downsd to 20.
For investors, staying above 30 EOY I be bullish into 2025. I am optimistic for March 2025 earnings n could create new ATH.
Those enter to trade at 25.5 this week is the time to unload at 29/30. I expect some resistance and goin back down. Breaking 25.5 i see further downsd to 20.
For investors, staying above 30 EOY I be bullish into 2025. I am optimistic for March 2025 earnings n could create new ATH.
3
$Hims & Hers Health (HIMS.US)$ not included or ? 🤔🤨🧐
"GLP-1: Barclays on why 2025 could be an inflection point"
https://uk.investing.com/news/stock-market-news/glp1-barclays-on-why-2025-could-be-an-inflection-point-3849788
"GLP-1: Barclays on why 2025 could be an inflection point"
https://uk.investing.com/news/stock-market-news/glp1-barclays-on-why-2025-could-be-an-inflection-point-3849788
1
1
$Hims & Hers Health (HIMS.US)$ u guys shld hv know last week y on 19th is important.
Anyway this drop in a good way saw the gap closed at 26-25. We saw strong buyers bought up from 23.5 to close 28 in the 1st 30mins.
Dont worry its all expected. Follow me for updates on $Hims & Hers Health (HIMS.US)$![]()
Anyway this drop in a good way saw the gap closed at 26-25. We saw strong buyers bought up from 23.5 to close 28 in the 1st 30mins.
Dont worry its all expected. Follow me for updates on $Hims & Hers Health (HIMS.US)$
8
8
No comment yet
Tom 07 : 22 20 19 17